Search

Your search keyword '"Jeffries, David J"' showing total 40 results

Search Constraints

Start Over You searched for: Author "Jeffries, David J" Remove constraint Author: "Jeffries, David J"
40 results on '"Jeffries, David J"'

Search Results

1. Impact of the introduction of pneumococcal conjugate vaccination on invasive pneumococcal disease and pneumonia in The Gambia: 10 years of population-based surveillance

2. Impact of the introduction of pneumococcal conjugate vaccination on pneumonia in The Gambia: population-based surveillance and case-control studies

3. Safety and immunogenicity of inactivated poliovirus vaccine when given with measles–rubella combined vaccine and yellow fever vaccine and when given via different administration routes: a phase 4, randomised, non-inferiority trial in The Gambia

4. Effect of the introduction of pneumococcal conjugate vaccination on invasive pneumococcal disease in The Gambia: a population-based surveillance study

6. Impact of the introduction of pneumococcal conjugate vaccination on invasive pneumococcal disease and pneumonia in The Gambia: 10 years of population-based surveillance

8. Access to health care and mortality of children under 5 years of age in the Gambia: a case-control study/Acces aux soins de sante et mortalite des enfants de moins de 5 ans en Gambie: etude cas-temoins/Acceso a atencion de salud y mortalidad de menores de 5 anos en Gambia: estudio de casos y controles

9. Longitudinal assessment of an ELISPOT test for Mycobacterium tuberculosis infection

11. Comparison of enzyme-linked immunospot assay and tuberculin skin test in healthy children exposed to mycobacterium tuberculosis

12. Quantitative T cell assay reflects infectious load of Mycobacterium tuberculosis in an endemic case contact model

13. Large-scale evaluation of enzyme-linked immunospot assay and skin test for diagnosis of Mycobacterium tuberculosis infection against a gradient of exposure in the Gambia

16. Supervised learning for the automated transcription of spacer classification from spoligotype films

17. Correction: Safety and Immunogenicity of the Candidate Tuberculosis Vaccine MVA85A in West Africa

20. Commercial Interferon Gamma Release Assays Compared to the Tuberculin Skin Test for Diagnosis of Latent Mycobacterium tuberculosis Infection in Childhood Contacts in the Gambia

23. Safety and Immunogenicity of the Candidate Tuberculosis Vaccine MVA85A in West Africa

24. Risk Factors for and Clinical Outcome of Congenital Cytomegalovirus Infection in a Peri-Urban West-African Birth Cohort

27. Maintenance of HIV-Specific CD4+ T Cell Help Distinguishes HIV-2 from HIV-1 Infection

28. Mycobacterium africanumElicits an Attenuated T Cell Response to Early Secreted Antigenic Target, 6 kDa, in Patients with Tuberculosis and Their Household Contacts

29. ESAT-6/CFP-10 Fusion Protein and Peptides for Optimal Diagnosis of Mycobacterium tuberculosis Infection by Ex Vivo Enzyme-Linked Immunospot Assay in The Gambia

30. Large‐Scale Evaluation of Enzyme‐Linked Immunospot Assay and Skin Test for Diagnosis ofMycobacterium tuberculosisInfection against a Gradient of Exposure in The Gambia

31. Staphylococcus aureus Carriers Neutralize Superantigens by Antibodies Specific for Their Colonizing Strain: A Potential Explanation for Their Improved Prognosis in Severe Sepsis.

32. Large-Scale Evaluation of Enzyme-Linked Immunospot Assay and Skin Test for Diagnosis of Mycobacterium tuberculosis Infection against a Gradient of Exposure in The Gambia.

33. Commercial Interferon Gamma Release Assays Compared to the Tuberculin Skin Test for Diagnosis of Latent Mycobacterium tuberculosisInfection in Childhood Contacts in the Gambia

34. ESAT-6/CFP-10 Fusion Protein and Peptides for Optimal Diagnosis of Mycobacterium tuberculosisInfection by Ex Vivo Enzyme-Linked Immunospot Assay in The Gambia

40. Production of TNF-alpha, IL-12(p40) and IL-17 can discriminate between active TB disease and latent infection in a West African cohort.

Catalog

Books, media, physical & digital resources